(Q79812026)

English

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

scientific article published on 01 March 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

hydroxycarbamide

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Anthony H. Goldstone

4

object named as

Anthony H Goldstone

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Alan K Burnett

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Donald Milligan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Archie G Prentice

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Mary F McMullin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Keith Wheatley

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1114-1124

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

The outcomes and costs of acute myeloid leukemia among the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of preleukemic syndromes to continuous infusion of low-dose cytarabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose cytosine arabinoside: partial remission of acute myeloid leukaemia without evidence of differentiation induction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of myeloid leukaemic cells: new possibilities for therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of all-trans retinoic acid on chemotherapy induced apoptosis and down-regulation of Bcl-2 in human myeloid leukaemia CD34 positive cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22496

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315155%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79812026&oldid=1774033480"